Gabapentin for Anxiety, Anger, and Irritability
Gabapentin is not FDA-approved for anxiety, anger, or irritability but may be considered as an off-label treatment option in specific clinical scenarios when first-line treatments have failed or are contraindicated. 1
Efficacy and Evidence
- Gabapentin has been used off-label for anxiety symptoms with some evidence of effectiveness, particularly in breast cancer survivors where it showed significant improvement in anxiety compared to placebo 2
- Limited evidence exists for gabapentin's use in generalized anxiety disorder (GAD), with only case reports rather than randomized controlled trials 3
- Gabapentin may help with symptoms of irritability and anger as part of its overall calming effect, though this is not well-studied as a primary indication 4
First-Line Treatment Options for Anxiety
- SSRIs and SNRIs are recommended as first-line pharmacological treatments for anxiety disorders with substantial evidence supporting their efficacy 5
- Cognitive behavioral therapy (CBT) is recommended as a first-line non-pharmacological treatment for anxiety disorders 5
- Benzodiazepines may be used for short-term management of severe anxiety but carry risks of dependence and are not recommended for long-term use 6
Safety Concerns with Gabapentin
FDA labeling warns of serious side effects including:
- Increased risk of suicidal thoughts and behaviors (approximately one additional case per 530 patients treated) 1
- Neuropsychiatric adverse reactions, particularly in pediatric patients (3-12 years) including emotional lability, hostility, and thought disorders 1
- Risk of physical dependence and withdrawal symptoms if stopped abruptly 1
Gabapentinoids (including gabapentin) have been associated with:
Appropriate Clinical Use
Consider gabapentin for anxiety when:
- First-line treatments (SSRIs, SNRIs, CBT) have failed or are contraindicated 5
- The patient has comorbid conditions that might benefit from gabapentin (such as neuropathic pain, seizures, or insomnia) 6, 8
- The patient has a history of substance use disorder and requires an alternative to benzodiazepines 2, 8
Dosing considerations:
Monitoring and Follow-up
- Monitor for emergence of suicidal thoughts or behaviors, particularly during initial treatment or dose changes 1
- Assess for neuropsychiatric effects including mood changes, hostility, or thought disturbances 1
- Evaluate treatment response regularly using standardized anxiety measures when possible 6
- Do not stop gabapentin abruptly; taper gradually to avoid withdrawal symptoms 1
Important Precautions
- Long-term efficacy and safety data for gabapentin in anxiety disorders are lacking 7
- Evidence for gabapentin in anxiety comes primarily from short-term studies and case reports 2, 3, 7
- Patients should be informed that this is an off-label use not specifically approved by the FDA 1
- Consider potential drug interactions, especially with other CNS depressants including opioids 1, 7
Conclusion
While gabapentin shows some promise for treating anxiety, anger, and irritability, it should be considered a second or third-line option after established treatments with stronger evidence bases have been tried. The decision to use gabapentin should carefully weigh potential benefits against risks of side effects and dependence.